These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19403015)

  • 21. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive evaluation of liver fibrosis using transient elastography.
    Castera L; Forns X; Alberti A
    J Hepatol; 2008 May; 48(5):835-47. PubMed ID: 18334275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver cirrhosis].
    Smirnova LI
    Feldsher Akush; 1991 May; 56(5):33-7. PubMed ID: 1874319
    [No Abstract]   [Full Text] [Related]  

  • 25. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
    Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
    Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpreting liver stiffness in the cirrhotic range.
    Bioulac-Sage P; Couffinhal T; Foucher J; Balabaud CP
    J Hepatol; 2009 Feb; 50(2):423-4; author reply 424-5. PubMed ID: 19070922
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage.
    Song ZZ
    Hepatology; 2008 Oct; 48(4):1351-2. PubMed ID: 18821615
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver biopsy in patients with haemophilia; in search for a reliable, non-invasive alternative.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K
    Haemophilia; 2008 May; 14(3):647-8. PubMed ID: 18282151
    [No Abstract]   [Full Text] [Related]  

  • 31. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining non-invasive methods for assessment of liver fibrosis.
    Bourlière M; Pénaranda G; Adhoute X; Oules V; Castellani P
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):73-9. PubMed ID: 18973849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver biopsy: the best, not the gold standard.
    Bedossa P; Carrat F
    J Hepatol; 2009 Jan; 50(1):1-3. PubMed ID: 19017551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
    J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Newly diagnosed liver cirrhosis 1].
    Schreiner P; Pfisterer D; Kröger A
    Praxis (Bern 1994); 2016 Apr; 105(8):429-33; 433-4. PubMed ID: 27078725
    [No Abstract]   [Full Text] [Related]  

  • 38. [HIV-HBV-coinfection--diagnosis and therapy].
    Koch S; Göbels K; Oette M; Heintges T; Erhardt A; Häussinger D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1873-7. PubMed ID: 16915550
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Ikegami T; Yamashita Y; Itoh S; Kuroda Y; Maehara Y
    Transplantation; 2008 Jan; 85(1):69-74. PubMed ID: 18192914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.